Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.6234
Nov 19 • 3:54 PM ET Dollar change-0.0245 Percentage change(-3.78%)
Aftermarket Close
0.6234
Aftermarket • 4:15 PM ET Dollar change0.0000 Percentage change(0.00%)
Index
-
Market Cap
1.90M
Enterprise Value
-9.01M
Income
-5.32M
Sales
0.03M
Book/sh
5.22
Cash/sh
3.80
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
7
IPO
Sep 01, 2020
P/E
-
Forward P/E
-
PEG
-
P/S
63.18
P/B
0.12
P/C
0.16
P/FCF
-
EV/EBITDA
-
EV/Sales
-300.48
Quick Ratio
5.07
Current Ratio
5.07
Debt/Eq
0.00
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-5.28
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
80.39% 55.23%
Sales past 3/5Y
- -
EPS Y/Y TTM
99.47%
Sales Y/Y TTM
-
EPS Q/Q
-3.64%
Sales Q/Q
-
Insider Own
0.00%
Insider Trans
-
Inst Own
11.92%
Inst Trans
0.17%
ROA
-35.16%
ROE
-43.75%
ROIC
-33.51%
Gross Margin
-3716.13%
Oper. Margin
-16629.03%
Profit Margin
-17158.06%
SMA20
-16.34%
SMA50
-25.05%
SMA200
-61.07%
Trades
Shs Outstand
0.03M
Shs Float
-
52W High
7.95 -92.16%
52W Low
0.60 3.23%
Volatility
11.92% 11.61%
ATR (14)
0.08
RSI (14)
34.49
Beta
1.12
Rel Volume
0.13
Avg Volume
228.09K
Volume
28,623
Perf Week
-20.77%
Perf Month
-18.40%
Perf Quarter
-37.48%
Perf Half Y
-57.01%
Perf YTD
-80.57%
Perf Year
-85.90%
Perf 3Y
-99.76%
Perf 5Y
-99.98%
Perf 10Y
-
Prev Close
0.65
Price
0.62
Change %
-3.78%
PRF Technologies Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. It offers PRF-110, an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized and extended post-operative analgesia. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
Executive ChairmanDr. Ehud Geller Ph.D.
Chief Financial OfficerMr. Eyal Broder
Ph.D.Dr. Sigal Aviel eMBA
Interim CEO & DirectorMr. Efraim Cohen-Arazi
Vice President of Pharmaceutical OperationsMs. Rita Keynan M.Sc.